Revenue has oscillated between roughly $3.3B and $5.2B with a 2026Q3 combined ratio of 90.8% and a 2026Q1 combined ratio of 107.7%, indicating underwriting results that are highly uneven quarter to quarter.
Markel Corporation (MKL) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Revenue | 17.13B | 16.59B | 16.75B | 15.71B | 11.81B | 12.92B | 9.64B | 9.52B | 6.95B | 6.06B | 5.61B | 5.37B | 5.13B | 4.32B | 3B | 2.63B | 2.23B | 2.07B | 1.98B | 2.48B | 2.52B | 2.2B | 2.26B | 2.09B | 1.77B | 1.4B | 1.09B | 524.32M | 426M | 419M | 366.7M |
| Revenue Growth % | 7.27% | -0.96% | 6.6% | 33.02% | -8.55% | 34.02% | 1.26% | 36.98% | 14.59% | 8.09% | 4.48% | 4.6% | 18.75% | 44.1% | 14.07% | 18.18% | 7.54% | 4.69% | -20.4% | -1.42% | 14.49% | -2.74% | 8.13% | 18.17% | 26.68% | 27.68% | 108.74% | 23.08% | 1.67% | 14.26% | 6.72% |
| Medical Costs & Claims | 5.85B | 5.08B | 7.48B | 7.63B | 8.41B | 7.03B | 6.26B | 4.67B | 4.3B | 4.22B | 3.25B | 2.75B | 2.92B | 2.34B | 1.58B | 1.72B | 1.37B | 992.86M | 1.27B | 1.85B | 1.9B | 1.95B | 1.98B | 1.85B | 1.6B | 1.5B | 1.07B | 440.33M | 328.18M | 120.1M | 0 |
| Medical Cost Ratio % | 34.15% | 30.62% | 44.64% | 48.57% | 71.17% | 54.38% | 64.91% | 49.03% | 61.94% | 69.56% | 57.91% | 51.26% | 56.88% | 54.09% | 52.81% | 65.52% | 61.66% | 47.98% | 64.2% | 74.62% | 75.44% | 88.64% | 87.61% | 88.64% | 90.48% | 107.36% | 97.82% | 83.98% | 77.04% | 28.66% | 0% |
| Gross Profit | 11.28B | 11.51B | 9.27B | 8.08B | 3.41B | 5.89B | 3.38B | 4.85B | 2.64B | 1.85B | 2.36B | 2.62B | 2.21B | 1.98B | 1.42B | 906.79M | 853.27M | 1.08B | 707.56M | 630.35M | 618.57M | 249.84M | 280.26M | 237.67M | 168.48M | -102.87M | 23.86M | 83.99M | 97.82M | 298.9M | 366.7M |
| Gross Margin % | 65.85% | 69.38% | 55.36% | 51.43% | 28.83% | 45.62% | 35.09% | 50.97% | 38.06% | 30.44% | 42.09% | 48.74% | 43.12% | 45.91% | 47.19% | 34.48% | 38.34% | 52.02% | 35.8% | 25.38% | 24.56% | 11.36% | 12.39% | 11.36% | 9.52% | -7.36% | 2.18% | 16.02% | 22.96% | 71.34% | 100% |
| Gross Profit Growth % | - | 24.12% | 14.75% | 137.29% | -42.21% | 74.25% | -30.3% | 83.46% | 43.27% | -21.83% | -9.77% | 18.26% | 11.53% | 40.18% | 56.13% | 6.27% | -20.73% | 52.14% | 12.25% | 1.9% | 147.59% | -10.86% | 17.92% | 41.07% | 263.78% | -531.08% | -71.59% | -14.14% | -67.27% | -18.49% | 6.72% |
| Operating Expenses | 8.91B | 8.78B | 5.64B | 5.43B | 3.56B | 2.76B | 2.38B | 2.57B | 2.65B | 1.76B | 1.73B | 1.88B | 1.77B | 1.62B | 1.1B | 716.59M | 557.76M | 877.83M | 867.39M | 58.4M | 65.17M | 63.84M | 56.22M | 56.09M | 50.78M | 79.33M | 75.67M | 30.55M | 22.44M | 20.1M | 8M |
| OpEx / Revenue % | 52.05% | 52.91% | 33.64% | 34.54% | 30.11% | 21.39% | 24.71% | 26.96% | 38.17% | 29% | 30.86% | 34.92% | 34.54% | 37.54% | 36.79% | 27.25% | 25.06% | 42.42% | 43.88% | 2.35% | 2.59% | 2.9% | 2.49% | 2.68% | 2.87% | 5.68% | 6.91% | 5.83% | 5.27% | 4.8% | 2.18% |
| Depreciation & Amortization | 172.86M | 347.92M | 342.36M | 319.73M | 309.45M | 336.39M | 307.07M | 269.24M | 227.85M | 203.87M | 194.15M | 200.99M | 203.58M | 190.07M | 87.33M | 70.57M | 53.59M | 31.17M | 31.19M | 30.53M | 34.04M | 36.34M | 31.34M | 39.26M | 28.23M | 41.91M | 32.4M | 12.86M | 7.3M | 7.3M | 10.9M |
| Combined Ratio % | 86.21% | 83.53% | 78.28% | 83.11% | 101.28% | 75.77% | 89.62% | 75.99% | 100.11% | 98.56% | 88.77% | 86.18% | 91.42% | 91.63% | 89.6% | 92.77% | 86.72% | 90.4% | 108.09% | 76.97% | 78.03% | 91.55% | 90.1% | 91.32% | 93.35% | 113.04% | 104.73% | 89.81% | 82.3% | 33.46% | 2.18% |
| Operating Income | 2.36B | 2.73B | 3.64B | 2.65B | -151.57M | 3.13B | 1B | 2.29B | -7.86M | 87.3M | 629.92M | 742.11M | 440.38M | 361.74M | 312.05M | 190.2M | 295.51M | 198.64M | -159.83M | 571.96M | 553.4M | 186M | 224.04M | 181.58M | 117.69M | -182.2M | -51.81M | 53.44M | 75.39M | 278.8M | 358.7M |
| Operating Margin % | 13.79% | 16.47% | 21.72% | 16.89% | -1.28% | 24.23% | 10.38% | 24.01% | -0.11% | 1.44% | 11.23% | 13.82% | 8.58% | 8.37% | 10.4% | 7.23% | 13.28% | 9.6% | -8.09% | 23.03% | 21.97% | 8.45% | 9.9% | 8.68% | 6.65% | -13.04% | -4.73% | 10.19% | 17.7% | 66.54% | 97.82% |
| Operating Income Growth % | - | -24.88% | 37.08% | 1850.86% | -104.84% | 212.84% | -56.23% | 29200.04% | -109% | -86.14% | -15.12% | 68.52% | 21.74% | 15.92% | 64.07% | -35.64% | 48.77% | 224.28% | -127.94% | 3.35% | 197.53% | -16.98% | 23.38% | 54.29% | 164.6% | -251.69% | -196.94% | -29.11% | -72.96% | -22.27% | 7.04% |
| EBITDA | 2.54B | 3.08B | 3.98B | 2.97B | 157.88M | 3.47B | 1.31B | 2.56B | 219.99M | 291.17M | 824.07M | 943.09M | 643.96M | 551.81M | 399.38M | 260.77M | 349.1M | 229.81M | -128.64M | 602.49M | 587.44M | 222.34M | 255.38M | 220.85M | 145.92M | -140.28M | -19.41M | 66.3M | 82.68M | 286.1M | 369.6M |
| EBITDA Margin % | 14.8% | 18.57% | 23.76% | 18.92% | 1.34% | 26.83% | 13.56% | 26.84% | 3.17% | 4.8% | 14.69% | 17.56% | 12.54% | 12.76% | 13.31% | 9.92% | 15.69% | 11.11% | -6.51% | 24.26% | 23.32% | 10.11% | 11.29% | 10.56% | 8.24% | -10.04% | -1.77% | 12.64% | 19.41% | 68.28% | 100.79% |
| Interest Expense | 204.16M | 205.91M | 204.3M | 185.08M | 196.06M | 183.58M | 177.58M | 171.69M | 154.21M | 132.45M | 129.9M | 118.3M | 117.44M | 114M | 92.76M | 86.25M | 73.66M | 53.97M | 48.21M | 56.25M | 65.17M | 63.84M | 56.22M | 51.96M | 40.1M | 48.65M | 52.35M | 25.15M | 20.41M | 20.1M | 8M |
| Non-Operating Income | -116.79M | -205.91M | -204.3M | -185.08M | -196.06M | -183.58M | -177.58M | -171.69M | -154.21M | -132.45M | -129.9M | -118.3M | -117.44M | -114M | -92.76M | -86.25M | -73.66M | -53.97M | -48.21M | -56.25M | -65.17M | -63.84M | -56.22M | -51.96M | -40.1M | -48.65M | -52.35M | -25.15M | -20.41M | 258.7M | 350.7M |
| Pretax Income | 2.33B | 2.73B | 3.64B | 2.65B | -151.57M | 3.13B | 1B | 2.29B | -7.86M | 87.3M | 629.92M | 742.11M | 440.38M | 361.74M | 312.05M | 190.2M | 295.51M | 198.64M | -159.83M | 571.96M | 553.4M | 186M | 224.04M | 181.58M | 117.69M | -182.2M | -51.81M | 53.44M | 75.39M | 66.3M | 37M |
| Pretax Margin % | 13.6% | 16.47% | 21.72% | 16.89% | -1.28% | 24.23% | 10.38% | 24.01% | -0.11% | 1.44% | 11.23% | 13.82% | 8.58% | 8.37% | 10.4% | 7.23% | 13.28% | 9.6% | -8.09% | 23.03% | 21.97% | 8.45% | 9.9% | 8.68% | 6.65% | -13.04% | -4.73% | 10.19% | 17.7% | 15.82% | 10.09% |
| Income Tax | 495.98M | 580.3M | 790.29M | 552.62M | -48.21M | 683.96M | 168.68M | 486.35M | 122.5M | -313.46M | 169.48M | 152.96M | 116.69M | 77.9M | 53.8M | 41.71M | 27.78M | -3.78M | -101.39M | 166.29M | 160.9M | 38.09M | 58.63M | 58.11M | 42.37M | -56.48M | -24.21M | 12.83M | 18.09M | 15.9M | -9.7M |
| Effective Tax Rate % | 21.29% | 21.24% | 21.73% | 20.82% | 31.81% | 21.85% | 16.86% | 21.28% | -1559.49% | -359.08% | 26.9% | 20.61% | 26.5% | 21.53% | 17.24% | 21.93% | 9.4% | -1.9% | 63.44% | 29.07% | 29.07% | 20.48% | 26.17% | 32% | 36% | 31% | 46.74% | 24% | 24% | 23.98% | -26.22% |
| Net Income | 1.79B | 2.11B | 2.75B | 2B | -216.28M | 2.42B | 816.03M | 1.79B | -128.18M | 395.27M | 455.69M | 582.77M | 321.18M | 281.02M | 253.38M | 142.03M | 266.79M | 201.64M | -58.77M | 405.67M | 392.5M | 147.91M | 165.41M | 123.48M | 75.32M | -125.72M | -27.59M | 40.61M | 57.29M | 50.4M | 46.7M |
| Net Margin % | 10.47% | 12.7% | 16.4% | 12.7% | -1.83% | 18.76% | 8.47% | 18.81% | -1.84% | 6.52% | 8.12% | 10.85% | 6.26% | 6.5% | 8.45% | 5.4% | 11.99% | 9.74% | -2.97% | 16.34% | 15.58% | 6.72% | 7.31% | 5.9% | 4.26% | -9% | -2.52% | 7.75% | 13.45% | 12.03% | 12.74% |
| Net Income Growth % | -13.79% | -23.3% | 37.62% | 1022.92% | -108.93% | 196.94% | -54.42% | 1496.84% | -132.43% | -13.26% | -21.81% | 81.45% | 14.29% | 10.91% | 78.41% | -46.77% | 32.31% | 443.11% | -114.49% | 3.35% | 165.36% | -10.58% | 33.96% | 63.93% | 159.92% | -355.63% | -167.94% | -29.11% | 13.68% | 7.92% | 35.36% |
| EPS (Diluted) | 144.02 | 169.22 | 199.32 | 146.98 | -23.72 | 176.51 | 55.63 | 129.07 | -9.21 | 25.81 | 31.27 | 41.74 | 22.27 | 22.48 | 25.89 | 14.60 | 27.27 | 20.52 | -5.99 | 40.64 | 39.40 | 14.80 | 16.41 | 12.31 | 7.65 | -14.73 | -3.99 | 7.20 | 10.17 | 8.92 | 8.30 |
| EPS Growth % | -11.88% | -15.1% | 35.61% | 719.65% | -113.44% | 217.29% | -56.9% | 1501.41% | -135.68% | -17.46% | -25.08% | 87.43% | -0.93% | -13.17% | 77.33% | -46.46% | 32.89% | 442.57% | -114.74% | 3.15% | 166.22% | -9.81% | 33.31% | 60.91% | 151.93% | -269.17% | -155.42% | -29.2% | 14.01% | 7.47% | 34.96% |
| EPS (Basic) | - | 169.74 | 199.69 | 147.32 | -23.72 | 176.92 | 55.67 | 129.25 | -9.21 | 25.89 | 31.41 | 41.99 | 22.38 | 22.57 | 25.96 | 14.66 | 27.31 | 20.54 | -5.99 | 40.73 | 40.43 | 15.05 | 16.79 | 12.55 | 7.67 | -14.73 | -3.99 | 7.27 | 10.41 | 9.20 | 8.58 |
| Diluted Shares Outstanding | 12.45M | 12.73M | 13.04M | 13.38M | 13.58M | 13.8M | 13.82M | 13.88M | 13.92M | 14.01M | 14.08M | 14.06M | 14.06M | 12.59M | 9.76M | 9.73M | 9.78M | 9.83M | 9.81M | 9.98M | 9.96M | 9.99M | 10.08M | 10.03M | 9.85M | 8.53M | 6.92M | 5.64M | 5.63M | 5.65M | 5.63M |
Quick answers to the most common questions about buying MKL stock.
For fiscal year 2025, Markel Corporation (MKL) reported total revenue of $16.59B. This represents a 4423.9% increase compared to $366.7M in 1996.
Markel Corporation (MKL) is profitable, generating $2.11B in net income for the fiscal year ending 2025 with a net profit margin of 12.7%.
Markel Corporation (MKL) reported an operating income of $2.73B, resulting in an operating profit margin of 16.5%. This margin reflects the operational efficiency of the business before interest and taxes.
Markel Corporation (MKL) generated $11.51B in gross profit for the year, representing a gross profit margin of 69.4%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Social inflation casualty reserve pressure
Metrics are mathematically derived from official filings.
Revenue Flattening Despite Volatile Quarters
Based on reported quarterly figures, Markel's revenue has oscillated between roughly $3.3B and $5.2B over the last ten quarters, with trailing top-line growth of -1.0% suggesting the premium base is no longer expanding meaningfully.
The sequential swings in revenue appear driven more by timing of premium recognition and Ventures activity than by a durable change in underwriting volume. A flat-to-slightly-declining trajectory is consistent with management's stated discipline of shrinking volume in softer pricing conditions rather than chasing share. Investors should monitor whether the next several quarters show renewed rate momentum or continued contraction, as the latter would weigh on float growth that underpins the holding company model.
Combined Ratio Swings Define Underwriting Profile
As reported in the quarterly income statement, Markel's combined ratio ranged from 70.8% to 107.7% across recent quarters, with the 2026Q1 print above 100% indicating an underwriting loss that required investment income to produce any profit.
The wide dispersion in combined ratio suggests catastrophe timing and reserve movements are contributing heavily to quarterly results rather than a steady underwriting run-rate. Loss ratios in the 30% to 55% band, which appear low relative to typical casualty-heavy books, may reflect favorable prior-year development or mix effects that warrant further investigation. Sustained readings above 100% would indicate the company is reliant on portfolio income to deliver earnings, a dependency investors should weigh against the reported net income figures.
Reserve Adequacy Questions Behind Earnings
Based on reported figures, the sharp drop in loss ratio during several quarters may partly reflect prior-year reserve releases, which would flatter current earnings if social inflation pressure on US casualty claims is not fully reflected in estimates.
Favorable development can mask weakness in current-year underwriting, and the reported volatility in loss ratios is consistent with this pattern. Given persistent social inflation in US casualty lines, reserve strengthening for older accident years remains a plausible future drag that is not yet visible in the reported numbers. Investors should track prior-year development disclosures closely, as these carry more information about true underwriting quality than headline combined ratios.
Net Income Driven by Equity Mark-to-Market
Net income in the reported quarters diverges sharply from operating income, with 2026Q1 showing an operating loss of $273.3M while the period's net result is also negative, and quarterly EPS swinging from -18.90 to 92.76 across the window.
Under current accounting rules, unrealized equity gains and losses flow through the income statement, making headline earnings a poor guide to operating health. The EPS volatility suggests the equity portfolio is contributing a large share of reported profit variance. Analysts should anchor on operating income and book value growth rather than quarterly net income when judging the investment engine.
Reported Earnings May Overstate Durability
The strongest challenge to Markel's reported earnings is that quarterly EPS of 92.76 in 2026Q2 and 59.25 in 2025Q3 appear to rely on favorable loss ratios and equity gains, which may not persist if casualty reserve development turns adverse.
If the lower loss ratios seen in some quarters reflect reserve releases rather than improved pricing, current profitability could be overstated relative to economic earnings. Equity-driven net income is inherently non-recurring and can reverse quickly, meaning the headline earnings trajectory may not indicate underlying franchise strength. Investors should weigh these possibilities before extrapolating recent profitability into forward valuation.